HLYK OTC
HealthLynked Corp.
1W: +12.7%
1M: -16.2%
3M: -30.6%
YTD: +44.2%
1Y: +24.0%
3Y: -52.8%
5Y: -95.2%
$2.22
-0.10 (-4.31%)
Weekly Expected Move ±14.5%
$2
$2
$2
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$3M
-47.4% ▼
5Y CAGR: -5.6%
Gross Profit
$3M
+24.0% ▲
Operating Income
-$5M
-12.7% ▼
Net Income
-$6M
-505.8% ▼
EPS (Diluted)
$-2.18
-459.0% ▼
EBITDA
-$4M
-58.7% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $6M | $9M | $6M | $6M | $3M |
| YoY Growth | +52.6% | +50.0% | -36.3% | -2.3% | -47.4% |
| Cost of Revenue | $1M | $3M | $463K | $3M | $96K |
| Gross Profit | $5M | $6M | $5M | $2M | $3M |
| Gross Margin | 81.0% | 67.2% | 92.1% | 41.0% | 96.8% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $6M | $8M | $8M | $4M | $3M |
| Operating Expenses | $8M | $11M | $11M | $7M | $8M |
| Operating Income | -$3M | -$5M | -$6M | -$4M | -$5M |
| Operating Margin | -50.1% | -54.8% | -100.9% | -72.6% | -155.5% |
| Interest Expense | $781K | $19K | $78K | $512K | $1M |
| Income Before Tax | -$6M | -$11M | -$8M | -$4M | -$6M |
| Tax Expense | $0 | -$102 | $0 | $0 | $0 |
| Net Income | -$6M | -$10M | -$9M | -$1M | -$6M |
| Net Margin | -100.3% | -113.2% | -150.5% | -17.7% | -203.8% |
| EPS (Diluted) | $-4.31 | $-4.63 | $-3.62 | $-0.39 | $-2.18 |
| EBITDA | -$5M | -$10M | -$7M | -$3M | -$4M |
| Shares Outstanding | 1M | 2M | 2M | 3M | 3M |